Pharmaceutical naming is extremely complex, given regulatory and legal constraints and parameters. The world’s most innovative and respected pharmaceutical companies continuously trust our brand creation agency and name safety partner, SafeMark, for proprietary, non-proprietary, and clinical trial verbal and visual branding. When you partner with us, you’re in great company, and joining a team with more than 220 years of combined leadership expertise in the pharmaceutical and healthcare sector.
WHY WE’RE DIFFERENT
A PHARMACEUTICAL BRANDING AGENCY WITH DECADES OF INDUSTRY EXPERTISE
With 200,000 drugs on the market and more than 1.3 million registered trademarks in Class 5, pharmaceutical naming has never been more elaborate. The difference of one letter could lead to a drug being mistakenly prescribed, resulting in patient harm, or even death. Our senior leadership team, with decades of pharmaceutical and healthcare branding expertise to their name, works directly on your project to navigate these hurdles and deliver creative, screened, and tested names and confidence.
NO NAMING DATABASES
Your brand isn’t cookie cutter, and we don’t utilize a previously concepted bank of names to pull from for your project. Our global team of brand naming experts approaches each project individually, to develop original, inventive ideas that are specific to you, your brand, your drug attributes, and your goals. We’re all about recycling, but not for the work we do for clients.
TRADEMARK PARALEGALS ON STAFF
Our team includes trademark paralegals who screen and vet each candidate we show to you. We want to make sure we are only putting viable options in front of your team and take the necessary steps up front to do so.
TRADEMARK & POCA ANALYSIS
Our paralegals employ a combination of tools that include 268 international trademark databases, along with Pharma-In-Use Legal Prescreen (Corsearch®) and Common-Law Prescreen. Name candidates are also screened with the FDA POCA system to assure that no presented options exceed a 75% threshold in combined Phonetic and Orthographic score.
GLOBAL LINGUISTICS EVALUATION
The world will likely be your stage, and making sure your brand is received well in every market you’ll enter is our top priority. This thorough evaluation is conducted in your 10 identified primary language markets, with in-country, native language-speaking professionals, to ensure the names communicate the correct messaging across all geographic regions.
UNPARALLELED NAME SAFETY TESTING
The Brandsymbol Regulatory Division is the industry-leader in robust and comprehensive regulatory consulting, safety testing, and package and label services for the pharmaceutical and healthcare industries.
IN IT UNTIL YOU WIN IT
We guarantee a partnership until the name is approved for your compound. Period.
A track record of success
We’ve created more than 122 healthcare brand identities…and we’re not looking to slow down any time soon. We want to be your pharmaceutical branding agency.
PHARMACEUTICAL BRANDING SUCCESS STORIES
WE’RE BUILDING BOLD BRANDS FOR OUR PHARMACEUTICAL PARTNERS
Pharma Branding Knowledge:
Key Considerations for Developing Strong Clinical Trial Branding
It’s true; clinical trial branding isn’t required. Government bodies don’t ask for branded trials, there are no legal guidelines informing the dos and don’ts of clinical trial branding. So why do companies brand their trials?
The Regulatory AI Revolution: How MOSAIQTM Is Reinventing Name Safety in Pharma
In pharmaceutical branding, creativity may spark the idea — but regulatory safety determines whether a name can ever reach the market. And with global agencies tightening linguistic, structural, and similarity requirements, name safety has become
The 2026 NICE Classification Update & Why it Matters for Trademark Strategy
Do trademarks affect you in your line of work? Do you file new applications for international trademarks? Do you managing global portfolios or advising clients? If any of these apply to you, you’ll want to
A study on how the Brand Name & Storage of Vaccine Products help in product selection and patient communication
In the fall of 2025, we conducted a short survey among 33 U.S.-based pharmacists asking their opinion regarding patient discussion, storage, and product selection of vaccines. Here is a summary of our findings. 1. What